insights_auto
Nega EDIT tushdi 2,41%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,82 US$
arrow_downward
-2,41%(-0,045) 1K
1,92 US$
arrow_upward
+5,21% (+0,095)bedtimeYopilgandan keyin
Savdolar yopilgan: 17-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
1,90 US$
Yuqori
1,94 US$
Past
1,82 US$
Bozor kapitali
281,67 mln
Oʻrtacha hajm
2,41 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
1,90 US$
Yuqori
1,94 US$
Past
1,82 US$
Bozor kapitali
281,67 mln
Oʻrtacha hajm
2,41 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
BigGo Finance
·
7 soat oldin
New York Stocks Fall for Fourth Straight Session Ahead of Nvidia Earnings; Dow Plunges 1.6%
ChartMill
·
7 soat oldin
S&P 500 After-Hours Gainers for Nov. 17, 2026
Fox Business
·
10 soat oldin
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Traders Union
·
4 soat oldin
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com